EndoGastric Solutions announces Coverage Verification by HealthNet for TIF® 2.0 Procedure with EsophyX® Device
Reflux sufferers in Arizona, California, Oregon and Washington now have access to less invasive reflux treatment option.
EndoGastric® Solutions Expands Commercial Leadership Team to Meet Increased Demand for TIF® Procedure for Reflux
EndoGastric Solutions®, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the addition of two senior executives to its leadership team: Martin Reid, Vice President of Sales, and Ted Stephens, Vice President of Marketing and Professional Education.
